These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mast cell disorders: A framework of allergy and hematology symptoms leading to personalized treatments. Castells MC Ann Allergy Asthma Immunol; 2021 Oct; 127(4):403-404. PubMed ID: 34593102 [No Abstract] [Full Text] [Related]
9. Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA). Dölle-Bierke S; Siebenhaar F; Burmeister T; Worm M J Allergy Clin Immunol; 2019 Nov; 144(5):1448-1450.e1. PubMed ID: 31415784 [No Abstract] [Full Text] [Related]
10. Bone Marrow Expression of Mast Cell Disorders. Sánchez-Muñoz L; Henriques AF; Alvarez-Twose I; Matito A Immunol Allergy Clin North Am; 2018 Aug; 38(3):379-395. PubMed ID: 30007458 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, prognosis, and risk factors in mastocytosis. Brockow K Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674 [TBL] [Abstract][Full Text] [Related]
12. Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis. Azaña JM; Torrelo A; Matito A Actas Dermosifiliogr; 2016; 107(1):5-14. PubMed ID: 26546030 [TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis with clonal mast cells in normal looking skin - a new entity? Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic criteria and classification of mastocytosis in 2014. Akin C; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670 [TBL] [Abstract][Full Text] [Related]
15. Mastocytosis: Moving the Field to Precision and Personalized Medicine. Castells MC Immunol Allergy Clin North Am; 2018 Aug; 38(3):xv-xvii. PubMed ID: 30007470 [No Abstract] [Full Text] [Related]
16. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
18. Kit Mutations: New Insights and Diagnostic Value. Falchi L; Verstovsek S Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460 [TBL] [Abstract][Full Text] [Related]
19. [IgE mediated anaphylaxis in a patient with systemic mastocytosis]. Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896 [TBL] [Abstract][Full Text] [Related]
20. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]